Berberine ameliorates collagen-induced arthritis in mice by restoring macrophage polarization via AMPK/mTORC1 pathway switching glycolytic reprogramming

Int Immunopharmacol. 2023 Nov;124(Pt B):111024. doi: 10.1016/j.intimp.2023.111024. Epub 2023 Oct 10.

Abstract

Dysfunction of macrophage polarization majorly contributes to the progression of rheumatoid arthritis (RA). Polarization and functions of activated macrophages are closely associated with the reprogramming of intracellular metabolisms. Previously, we demonstrated that the anti-arthritis effect of berberine (BBR) in rats with adjuvant-induced arthritis (AA) may be related to AMP-activated protein kinase (AMPK) activation (a key regulator in the biological energy metabolism), and balanced macrophage polarization. However, the specific molecular mechanism of BBR in macrophage metabolism is yet to be elucidated. In this study, we clarified that BBR ameliorated articular inflammation and restored M1/M2 ratio in collagen-induced arthritis (CIA) mice in an AMPK-dependent manner. Mechanistically, BBR reversed the effects of mTORC1 agonist leucine (Leu) on regulating macrophage polarization through activation of AMPK to switch glycolytic reprogramming. Furthermore, BBR inhibition of mTORC1 rely on activation of AMPK to phosphorylate raptor and TSC2 instead of destroying its structure. Our study revealed that the activation of AMPK is required for the BBR-mediated anti-arthritis effect by downregulating mTORC1/HIF-1α and inhibiting the glycolysis in M1 macrophages.

Keywords: AMPK; Berberine; Collagen-induced arthritis; Glycolysis; Macrophage polarization; mTORC1.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Arthritis, Experimental* / drug therapy
  • Arthritis, Experimental* / metabolism
  • Berberine* / pharmacology
  • Berberine* / therapeutic use
  • Glycolysis
  • Macrophages
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • Rats

Substances

  • AMP-Activated Protein Kinases
  • Berberine
  • Mechanistic Target of Rapamycin Complex 1